-
Posted: March 1st, 2018, 3:00am GMT
Conditions: Pediatric Brain Tumors
Interventions: Drug: FET PET/MRI
Sponsors: University of Alabama at Birmingham
Terminated
-
Posted: February 26th, 2018, 3:00am GMT
Conditions: Childhood Solid Tumor; Childhood Lymphoma; Relapsed Cancer; Refractory Cancer; Adult Solid Tumor; Adult Lymphoma
Interventions: Drug: Pembrolizumab; Drug: Decitabine; Radiation: Hypofractionated Index Site Radiation
Sponsors: Children's Hospital Medical Center, Cincinnati
Active, not recruiting
-
Posted: February 22nd, 2018, 3:00am GMT
Conditions: Respiratory Depression
Interventions: Drug: Fentanyl
Sponsors: University of Alabama at Birmingham
Active, not recruiting
-
Posted: February 19th, 2018, 3:00am GMT
Conditions: Prostate Cancer Metastatic
Interventions: Drug: ODM-208; Drug: Midazolam
Sponsors: Orion Corporation, Orion Pharma
Active, not recruiting
-
Posted: February 15th, 2018, 3:00am GMT
Conditions: Pancreatic Cancer
Interventions: Drug: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml; Drug: Propofol+ Rocuronium+ Fentanyl + Inhalational; Procedure: Open Pancreaticoduodenectomy
Sponsors: Memorial Sloan Kettering Cancer Center
Active, not recruiting
-
Posted: February 6th, 2018, 3:00am GMT
Conditions: Recurrent Glioblastoma Multiforme; Primary Glioblastoma Multiforme; Brain Neoplasms, Malignant; Leptomeningeal Disease (LMD)
Interventions: Radiation: Radiation Therapy; Drug: AZD1390
Sponsors: AstraZeneca
Recruiting
-
Posted: February 6th, 2018, 3:00am GMT
Conditions: Oropharyngeal Cancer; HPV-Related Squamous Cell Carcinoma
Interventions: Drug: Gabapentin
Sponsors: University of Chicago
Recruiting